Tevogen Inc. Regains Nasdaq Listing Compliance

Tevogen Inc. confirmed on September 29, 2026, that it has regained compliance with Nasdaq's $50 million minimum market value of listed securities (MVLS) rule. The company had previously regained compliance with the public float requirement. Both compliance matters are now resolved.